Cargando…
Newer Oral Anticoagulant Agents: A New Era in Medicine
After a gap of almost 60 years following the development of warfarin, 2 new categories of oral anticoagulant agents have been approved for clinical use – the direct thrombin inhibitors and factor Xa inhibitors. These agents promise to be more convenient to administer with fixed dosing but still have...
Autores principales: | Goel, Ramil, Srivathsan, Komandoor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3406275/ https://www.ncbi.nlm.nih.gov/pubmed/22708914 http://dx.doi.org/10.2174/157340312801784934 |
Ejemplares similares
-
Operative survival in patients with acute aortic disease in the era of newer oral anticoagulants
por: Bjørnstad, Johannes Lagethon, et al.
Publicado: (2020) -
The Newer Era of Veterinary Medicine
por: Law, James
Publicado: (1902) -
Newer Oral Anticoagulants: Stroke Prevention and Pitfalls
por: Patel, Anand, et al.
Publicado: (2016) -
Dabigatran-Induced Acute Interstitial Nephritis: An Important Complication of Newer Oral Anticoagulation Agents
por: Patel, Swapnil, et al.
Publicado: (2018) -
Venous Thromboembolism in Cancer: An Update of Treatment and Prevention in the Era of Newer Anticoagulants
por: Qureshi, Waqas, et al.
Publicado: (2016)